<DOC>
	<DOCNO>NCT02898350</DOCNO>
	<brief_summary>Prospective , randomize , split lesion treatment 4 study Arms evaluate safety efficacy combine treatment minimize surgical scar , include post Moh 's surgery .</brief_summary>
	<brief_title>Surgical Scar Treatment With Pulsed Dye Laser Combination With CO2 Laser</brief_title>
	<detailed_description>Prospective , Randomized , Split lesion treatment 4 study Arms : 1 ) treatment pulse dye laser ( PDL ) , 2 ) treatment CO2 laser , 3 ) PDL CO2 laser combine treatment , 4 ) split scar combine laser additional single CO2 laser treatment immediately post-surgery vs. treatment .</detailed_description>
	<criteria>Comprehension , willingness sign , Informed Consent Form . Have plan surgical procedure , expect result least one linear surgical scar least 3.0 cm . Be healthy male female least 18 year old . Fitzpatrick skin type IV . Willingness follow treatment followup schedule posttreatment care instruction . Non pregnant and/or breast feeding , applicable . Willingness provide brief medical history include disclosure prescribe overthecounter medication take within past 6 month . Agree follow undergo studyrelated procedure . Use daily use sunblock SPF 30 high duration study . 1 . Pregnant and/or breastfeeding . 2 . Fitzpatrick skin type VI . 3 . Prior treatment surgical scar treat study . 4 . Having history disease stimulate heat , recurrent Herpes Simplex treat area , unless treatment conduct follow prophylactic regimen . 5 . Use Isotretinoin systemic retinoids within past 6 month . 6 . Use topical retinoids therapeutic topicals treatment area past 2 month . 7 . Use medication induce photosensitivity 595 10,600 nm wavelength range . 8 . Suffering current history significant skin condition treat area inflammatory skin condition . 9 . History immunosuppression/immune deficiency disorder currently use immunosuppressive medication . 10 . Having uncontrolled disease disorder one per investigator 's judgment might make unsafe subject participate study . 11 . Excessively tanned area treat unable/unlikely refrain tan sun exposure duration study . 12 . Participation another investigational device investigational drug study within 30 day prior enrollment , per investigator 's clinical judgment . 13 . As per Investigator 's discretion , physical mental condition might make unsafe subject participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>